PROVISE Trademark

Trademark Overview


On Tuesday, August 17, 2021, a trademark application was filed for PROVISE with the United States Patent and Trademark Office. The USPTO has given the PROVISE trademark a serial number of 90886661. The federal status of this trademark filing is REGISTERED as of Tuesday, October 25, 2022. This trademark is owned by MERCK KGAA. The PROVISE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Biological research, clinical research in the field of medicine, the prevention, treatment and management of illness and medical research; Scientific research; Pharmaceutical research and development; Preparation of reports relating to scientific research; Research and development services in the field of antibodies; Research and testing services in the fields of bacteriology and virology; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Conducting clinical trials for pharmaceutical products; Consultancy relating to pharmaceutical research and development; Preparation of scientific reports; Conducting of scientific studies in the field(s) of medicine, the prevention, treatment and management of illness; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Advisory services relating to scientific research; Pharmaceutical product evaluation
provise

General Information


Serial Number90886661
Word MarkPROVISE
Filing DateTuesday, August 17, 2021
Status700 - REGISTERED
Status DateTuesday, October 25, 2022
Registration Number6883180
Registration DateTuesday, October 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 9, 2022

Trademark Statements


Goods and ServicesBiological research, clinical research in the field of medicine, the prevention, treatment and management of illness and medical research; Scientific research; Pharmaceutical research and development; Preparation of reports relating to scientific research; Research and development services in the field of antibodies; Research and testing services in the fields of bacteriology and virology; Research and development of vaccines and medicines; Development of pharmaceutical preparations and medicines; Conducting clinical trials for pharmaceutical products; Consultancy relating to pharmaceutical research and development; Preparation of scientific reports; Conducting of scientific studies in the field(s) of medicine, the prevention, treatment and management of illness; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Advisory services relating to scientific research; Pharmaceutical product evaluation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMERCK KGAA
Party Type30 - Original Registrant
Legal Entity Type99 - Other
Address64293 Darmstadt F128/002
DE

Party NameMERCK KGAA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
Address64293 Darmstadt F128/002
DE

Party NameMERCK KGAA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address64293 Darmstadt F128/002
DE

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 9, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 9, 2022PUBLISHED FOR OPPOSITION
Wednesday, July 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 6, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 13, 2022ASSIGNED TO EXAMINER
Thursday, June 9, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 9, 2022ASSIGNED TO LIE
Wednesday, June 1, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 27, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 27, 2021NON-FINAL ACTION E-MAILED
Monday, December 27, 2021NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021ASSIGNED TO EXAMINER
Tuesday, October 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, August 20, 2021NEW APPLICATION ENTERED IN TRAM